Genomic EQA Directory

Overview:

GenQA offers an extensive repertoire of EQAs to cover a broad spectrum of biomarker testing in solid tumours. This has increased over the years as GenQA is committed to rapidly developing new EQAs to align with identification of new specific treatment biomarkers.  The EQAs reflect material tested in clinical practice e.g. FFPE and DNA derived from patient samples, in addition to plasma where appropriate. Laboratories providing molecular analysis of solid tumours, can participate using any standard genomic laboratory protocol.

To further support such laboratories, GenQA also offers an online somatic variant classification EQA which allows for the inclusion of clinical cases / conditions / genes where patient samples may be limited. In addition, our Tissue-i module enables individuals to benchmark the accuracy of their assessment of tumour and cellularity content of H&E stained formalin fixed paraffin embedded (FFPE) tissue and fresh frozen (FF) tissue samples for subsequent molecular testing.

Summary information:

Assess your molecular testing and reporting of a variety of genes in different tumour types.

• EQAs delivered in accordance with the international standard ISO 17043 for proficiency testing providers.
• Cases based on real clinical scenarios, using validated samples.
• Any standard laboratory analysis methods
• 6-8 weeks to test samples and submit results
• Submitted results are assessed by an expert scientific panel.
• Each participant receives an Individual Laboratory Report (ILR) and EQA summary report detailing general findings, a summary of methodologies used, common errors and benchmarking against other laboratories worldwide.

Offers:

Enrol in a colorectal cancer, melanoma and a lung cancer EQA and get Classification of Somatic solid tumour variants EQA for free!